Raloxifene 60 mg Tablet is a selective estrogen receptor modulator (SERM) used primarily to treat osteoporosis in postmenopausal women. Besides its bone-strengthening benefits, it also plays a role in reducing the risk of breast cancer. Raloxifene works by binding to estrogen receptors in breast tissue, which can help block estrogen's effects that might lead to the growth of estrogen-dependent breast cancer cells.

Clinical studies have shown that raloxifene can significantly lower the risk of invasive breast cancer in postmenopausal women, particularly those at high risk for the disease. Unlike traditional estrogen therapies, raloxifene does not increase the risk of uterine cancer, making it a safer alternative for breast cancer prevention.

While raloxifene is beneficial for reducing breast cancer risk, women need to discuss their individual risk factors and treatment options with their healthcare provider to determine the most appropriate approach for their health needs.